The development of Monoclonal antibodies (mAbs) has also allowed researchers to
understand the complexity of diseases better and find new treatments for difficult-to-treat …

For more than a century, therapeutic antibodies held the promise of providing specific cures
for a wide range of diseases. It was not till the monoclonal era that the difficulties with purity …

In the 36 years since the methodology of generating monoclonal antibodies (mAbs) was
introduced, mAbs have become the most therapeutically useful and economically lucrative …

Monoclonal antibodies are routinely used in several fields but the great challenge has been
their use as therapeutic agents for the treatment of diseases, such as breast cancer …

Since the first publication by Kohler and Milstein on the production of mouse monoclonal
antibodies (mAbs) by hybridoma technology, mAbs have had a profound impact on …

Awareness to monoclonal antibodies (mABs) has been intensely increasing yearly. Due to
highly specific targeting of antigens, mABs can be used for the treatment of various type of …

Introduction. Recently, monoclonal antibodies (mAbs) have become powerful human
therapeutics in the diagnosis and treatment of many diseases. Drugs based on mAbs are …

Therapeutic Delivery (2011) 2 (3) 330 future science group 402 publications. Replacing
'Phase II'with 'Phase I'yielded 372 publications. Since clinical trials are time consuming, this …

Monoclonal antibodies (mAbs) are extensively employed for disease diagnosis and
treatment because of their high homogeneity and antigen specificity. In recent years …

Therapeutic monoclonal antibodies (mAbs) are the fastest growing class of new therapeutic
molecules. They hold great promises for the treatment of a variety of diseases, including …